Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya Hanna

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMC Pulmonary Medicine|April 23, 2022
Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotypeMona Nili, David Singer, Maya Hanna
Journal of Managed Care & Specialty Pharmacy|October 27, 2018
Predicting Diagnosis of Alzheimer's Disease and Related Dementias Using Administrative ClaimsJennifer S Albrecht, Maya Hanna, Dure Kim, et al.
Alzheimer Disease and Associated Disorders|October 10, 2018
Increased Health Care Utilization in Dementia Subtypes Before DiagnosisJennifer S Albrecht, Maya Hanna, Dure Kim, et al.
Alzheimer Disease and Associated Disorders|January 26, 2019
An Algorithm to Characterize a Dementia Population by Disease SubtypeJennifer S Albrecht, Maya Hanna, Rhonda L Randall, et al.
The Oncologist|August 25, 2025
Predictors of outcomes in advanced non-small cell lung cancer treated with pembrolizumab maintenanceVamsidhar Velcheti, Xuezheng Sun, Maya Hanna, et al.
Oncology and Therapy|January 8, 2025
Niraparib as First-Line Maintenance Therapy in Patients with Stage III Ovarian Cancer and No Visible Residual Disease: AR1ZE Real-World StudyDana M Chase, Maya Hanna, Jonathan T Lim, et al.
European Journal of Haematology|December 26, 2023
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and SpainMoritz Lehne, K Martin Kortüm, Karthik Ramasamy, et al.
Frontiers in Medicine|December 11, 2023
Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experimentCaitlin Thomas, Sikander Ailawadhi, Rakesh Popat, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 6, 2013
Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humansBenjamin S Maciejewski, Jennifer L LaPerle, Danny Chen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMC Pulmonary Medicine|April 23, 2022
Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotypeMona Nili, David Singer, Maya Hanna
Journal of Managed Care & Specialty Pharmacy|October 27, 2018
Predicting Diagnosis of Alzheimer's Disease and Related Dementias Using Administrative ClaimsJennifer S Albrecht, Maya Hanna, Dure Kim, et al.
Alzheimer Disease and Associated Disorders|October 10, 2018
Increased Health Care Utilization in Dementia Subtypes Before DiagnosisJennifer S Albrecht, Maya Hanna, Dure Kim, et al.
Alzheimer Disease and Associated Disorders|January 26, 2019
An Algorithm to Characterize a Dementia Population by Disease SubtypeJennifer S Albrecht, Maya Hanna, Rhonda L Randall, et al.
The Oncologist|August 25, 2025
Predictors of outcomes in advanced non-small cell lung cancer treated with pembrolizumab maintenanceVamsidhar Velcheti, Xuezheng Sun, Maya Hanna, et al.
Oncology and Therapy|January 8, 2025
Niraparib as First-Line Maintenance Therapy in Patients with Stage III Ovarian Cancer and No Visible Residual Disease: AR1ZE Real-World StudyDana M Chase, Maya Hanna, Jonathan T Lim, et al.
European Journal of Haematology|December 26, 2023
Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and SpainMoritz Lehne, K Martin Kortüm, Karthik Ramasamy, et al.
Frontiers in Medicine|December 11, 2023
Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experimentCaitlin Thomas, Sikander Ailawadhi, Rakesh Popat, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 6, 2013
Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humansBenjamin S Maciejewski, Jennifer L LaPerle, Danny Chen, et al.
Pageof 1